The timing of pericardial drainage catheter removal and restart of the anticoagulation in patients suffered from perioperative pericardial tamponade during atrial fibrillation catheter ablation and uninterrupted dabigatran: Experiences from 20 cases.
10.3760/cma.j.cn112148-20220923-00743
- Author:
Xin ZHAO
1
;
Wen Li DAI
1
;
Xin SU
2
;
Jia Hui WU
1
;
Chang Qi JIA
1
;
Li FENG
1
;
Man NING
1
;
Yan Fei RUAN
1
;
Song ZUO
1
;
Rong HU
1
;
Xin DU
1
;
Jian Zeng DONG
1
;
Chang Sheng MA
1
Author Information
1. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
2. Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Atrial Fibrillation/drug therapy*;
Dabigatran/therapeutic use*;
Cardiac Tamponade/complications*;
Anticoagulants/therapeutic use*;
Retrospective Studies;
Treatment Outcome;
Drainage/adverse effects*;
Catheter Ablation;
Catheters/adverse effects*
- From:
Chinese Journal of Cardiology
2023;51(1):45-50
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the timing of pericardial drainage catheter removal and restart of the anticoagulation in patients with atrial fibrillation (AF) suffered from perioperative pericardial tamponade during atrial fibrillation catheter ablation and uninterrupted dabigatran. Methods: A total of 20 patients with pericardial tamponade, who underwent AF catheter ablation with uninterrupted dabigatran in Beijing Anzhen Hospital from January 2019 to August 2021, were included in this retrospective analysis. The clinical characteristics of enrolled patients, information of catheter ablation procedures, pericardial tamponade management, perioperative complications, the timing of pericardial drainage catheter removal and restart of anticoagulation were analyzed. Results: All patients underwent pericardiocentesis and pericardial effusion drainage was successful in all patients. The average drainage volume was (427.8±527.4) ml. Seven cases were treated with idarucizumab, of which 1 patient received surgical repair. The average timing of pericardial drainage catheter removal and restart of anticoagulation in 19 patients without surgical repair was (1.4±0.7) and (0.8±0.4) days, respectively. No new bleeding, embolism and death were reported during hospitalization and within 30 days following hospital discharge. Time of removal of pericardial drainage catheter, restart of anticoagulation and hospital stay were similar between patients treated with idarucizumab or not. Conclusion: It is safe and reasonable to remove pericardial drainage catheter and restart anticoagulation as soon as possible during catheter ablation of atrial fibrillation with uninterrupted dabigatran independent of the idarucizumab use or not in case of confirmed hemostasis.
